https://www.cancernetwork.com/view/ofranergene-obadenovec-receives-fast-track-designation-from-fda-for-platinum-resistant-ovarian-cancer
Ofranergene Obadenovec Receives Fast Track Designation From FDA for Platinum-Resistant Ovarian...
May 16, 2026 - Patients with platinum-resistant ovarian cancer may benefit from treatment with ofranergene obadenovec, which received fast track designation from the FDA.
fast track